<DOC>
	<DOCNO>NCT00904280</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety tolerability oxymorphone ER analgesic cancer lower back pain subject chronic moderate severe pain .</brief_summary>
	<brief_title>Open-Label Extension Evaluate Long-Term Safety , Tolerability Analgesic Efficacy</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Oxymorphone</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>The subject enrol study must previously randomize dosed doubleblind treatment period study EN3202016 EN3202019 complete exit visit study . Males female , age 18 75 year , inclusively . The subject continue chronic moderate severe back cancer pain require opioid medication . Women must continue nonchildbearing potential . The subject experience serious drug relate adverse event study EN3202016 EN3202019 . The subject withdraw EN3202016 EN3202019 reason lack efficacy . Subjects know allergy opiateclass narcotic agent ( morphine , codeine , hydrocodone , propoxyphene , meperidine , oxycodone , etc . ) naproxen , subject medical condition opiate medically contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>